# MedTech Solutions -- Risk Register

**Status:** PRELIMINARY (Pre-Discovery)
**Last Updated:** [Date]
**Risk Owner:** Engagement Lead

---

## Risk Scoring Methodology

**Likelihood:** 1 (Rare) | 2 (Unlikely) | 3 (Possible) | 4 (Likely) | 5 (Almost Certain)
**Impact:** 1 (Negligible) | 2 (Minor) | 3 (Moderate) | 4 (Major) | 5 (Critical)
**Risk Score:** Likelihood x Impact (1-25)
**Rating:** Low (1-6) | Medium (7-12) | High (13-19) | Critical (20-25)

---

## Risk Summary Dashboard

| Rating | Count | Trend |
|--------|-------|-------|
| Critical | 2 | -- |
| High | 5 | -- |
| Medium | 7 | -- |
| Low | 3 | -- |
| **Total** | **17** | -- |

---

## Critical Risks

### R-001: HIPAA Compliance Violation During AI Implementation
| Attribute | Value |
|-----------|-------|
| **Category** | Regulatory / Compliance |
| **Likelihood** | 3 (Possible) |
| **Impact** | 5 (Critical) |
| **Risk Score** | 15 -- HIGH |
| **Description** | AI systems processing PHI could create compliance gaps if not properly designed, resulting in potential HIPAA violations, fines ($100-$50K per violation, up to $1.5M/year per category), and reputational damage. |
| **Trigger Indicators** | PHI used in model training without de-identification; AI vendor without BAA; data transmitted without encryption; audit findings. |
| **Mitigation Strategy** | 1) Privacy-by-design approach for all AI systems. 2) BAA execution with all AI/cloud vendors. 3) PHI de-identification for ML training data. 4) HIPAA security assessment before each deployment. 5) Engage privacy officer from project inception. |
| **Contingency Plan** | Breach notification procedures per HIPAA. Legal counsel engagement. HHS OCR reporting if required. Immediate system isolation if breach detected. |
| **Owner** | Engagement Lead + MedTech Privacy Officer |
| **Status** | Open -- Monitoring |

### R-002: Scope Creep from Undefined Executive Vision
| Attribute | Value |
|-----------|-------|
| **Category** | Project Management |
| **Likelihood** | 5 (Almost Certain) |
| **Impact** | 4 (Major) |
| **Risk Score** | 20 -- CRITICAL |
| **Description** | CEO's vague directive to "use AI to modernize operations" creates high risk of expanding scope, shifting priorities, and unrealistic expectations. Without clear boundaries, the project could become unfocused and fail to deliver measurable value. |
| **Trigger Indicators** | Frequent priority changes; new AI use cases added without removing others; stakeholders referencing capabilities not in scope; budget conversations avoided. |
| **Mitigation Strategy** | 1) Discovery phase to define concrete scope. 2) Phased roadmap with clear deliverables per phase. 3) Executive steering committee with monthly scope reviews. 4) Formal change request process. 5) Quick wins to demonstrate value and anchor expectations. |
| **Contingency Plan** | Re-scope engagement to most impactful initiatives. Present trade-off analysis to leadership. Invoke change request process with cost/timeline impact. |
| **Owner** | Engagement Lead |
| **Status** | Open -- Active |

---

## High Risks

### R-003: EHR Integration Complexity
| Attribute | Value |
|-----------|-------|
| **Category** | Technical |
| **Likelihood** | 4 (Likely) |
| **Impact** | 4 (Major) |
| **Risk Score** | 16 -- HIGH |
| **Description** | The existing EHR system may have limited API capabilities, proprietary interfaces, or vendor restrictions that significantly complicate integration with new AI systems. Healthcare EHR integrations are notoriously complex and time-consuming. |
| **Trigger Indicators** | EHR vendor unresponsive; limited API documentation; custom interface requirements; vendor charges for integration support. |
| **Mitigation Strategy** | 1) Early technical spike to assess EHR API capabilities. 2) Engage EHR vendor in discovery phase. 3) Budget for integration middleware (Mirth Connect, etc.). 4) Design for HL7 FHIR where possible. 5) Plan for manual workarounds as interim. |
| **Contingency Plan** | Implement adjacent systems with manual bridge to EHR. Use screen scraping/RPA as last resort. Consider EHR migration if integration is untenable (long-term). |
| **Owner** | Technical Architect |
| **Status** | Open -- Pending Discovery |

### R-004: IT Team Capacity and Skill Gaps
| Attribute | Value |
|-----------|-------|
| **Category** | Organizational / Resource |
| **Likelihood** | 4 (Likely) |
| **Impact** | 3 (Moderate) |
| **Risk Score** | 12 -- MEDIUM |
| **Description** | The 12-person IT team likely has limited AI/ML experience and may be at capacity supporting existing operations. Adding AI initiatives without addressing capacity could lead to burnout, project delays, or existing system neglect. |
| **Trigger Indicators** | IT team pushback on timelines; existing support tickets increasing; team members declining meeting invitations; knowledge transfer not sticking. |
| **Mitigation Strategy** | 1) Assess team skills and capacity during discovery. 2) Phased implementation to manage load. 3) Embedded knowledge transfer during implementation. 4) Recommend targeted training/certifications. 5) Budget for temporary IT augmentation if needed. |
| **Contingency Plan** | Bring in contract resources for operational IT during implementation. Reduce implementation velocity. Outsource specific capabilities (managed services). |
| **Owner** | Engagement Lead + CTO |
| **Status** | Open -- Pending Discovery |

### R-005: Clinical Staff Resistance to Change
| Attribute | Value |
|-----------|-------|
| **Category** | Organizational / Change Management |
| **Likelihood** | 4 (Likely) |
| **Impact** | 4 (Major) |
| **Risk Score** | 16 -- HIGH |
| **Description** | Physicians and clinical staff may resist new workflows, especially if they perceive AI as adding work, reducing autonomy, or threatening their roles. Poor adoption would undermine the entire initiative. |
| **Trigger Indicators** | Low pilot participation; workarounds that bypass new systems; vocal physician opposition; "we've always done it this way" sentiment. |
| **Mitigation Strategy** | 1) Identify physician champions early. 2) Involve clinical staff in design process. 3) Demonstrate time savings (not just efficiency). 4) Start with administrative AI (intake, scheduling) before clinical AI. 5) Formal change management program. 6) Pilot at most receptive clinic first. |
| **Contingency Plan** | Slow rollout and increase training. Modify solution based on clinical feedback. Executive mandate as last resort (with appropriate communication). |
| **Owner** | Change Management Lead + CMO |
| **Status** | Open -- Pending Discovery |

### R-006: Data Quality Insufficient for AI/ML
| Attribute | Value |
|-----------|-------|
| **Category** | Technical / Data |
| **Likelihood** | 4 (Likely) |
| **Impact** | 3 (Moderate) |
| **Risk Score** | 12 -- MEDIUM |
| **Description** | Paper-based processes suggest data may be incomplete, inconsistent, or siloed. AI/ML models require clean, structured data. Poor data quality could delay AI deployments or produce unreliable results. |
| **Trigger Indicators** | High duplicate patient rates; missing data fields; inconsistent coding; data isolated in department silos; no master patient index. |
| **Mitigation Strategy** | 1) Data quality assessment during discovery. 2) Data cleansing phase before ML model training. 3) Start with rule-based automation before ML where data is poor. 4) Implement data quality monitoring. 5) Establish data governance framework. |
| **Contingency Plan** | Extend Phase 1 timeline to include data remediation. Use vendor-provided pre-trained models where possible. Implement manual validation layers. |
| **Owner** | Data Engineer + CTO |
| **Status** | Open -- Pending Discovery |

### R-007: Budget Constraints or Misalignment
| Attribute | Value |
|-----------|-------|
| **Category** | Financial |
| **Likelihood** | 3 (Possible) |
| **Impact** | 4 (Major) |
| **Risk Score** | 12 -- MEDIUM |
| **Description** | CEO's budget vagueness could mean the actual available budget is significantly lower than what the full modernization requires. Misalignment between cost expectations and reality could stall or kill the project. |
| **Trigger Indicators** | Budget discussions deferred repeatedly; sticker shock at proposal; request to "do it all for less"; CFO not engaged. |
| **Mitigation Strategy** | 1) Address budget in CTO call (range, not specifics). 2) ROI-driven business cases for each initiative. 3) Phase 0/1 as low-risk entry point. 4) Quick wins to demonstrate value before larger investment. 5) Engage CFO early. |
| **Contingency Plan** | Reduce scope to highest-ROI initiatives only. Explore vendor financing or SaaS models to reduce upfront cost. Consider phased payment structure. |
| **Owner** | Engagement Lead |
| **Status** | Open -- Active |

---

## Medium Risks

### R-008: Vendor Lock-in with AI/Cloud Services
| Attribute | Value |
|-----------|-------|
| **Category** | Technical / Strategic |
| **Likelihood** | 3 (Possible) |
| **Impact** | 3 (Moderate) |
| **Risk Score** | 9 -- MEDIUM |
| **Description** | Heavy reliance on specific AWS AI services or healthcare AI vendors could create lock-in that limits future flexibility and increases long-term costs. |
| **Mitigation Strategy** | 1) Prefer open standards (FHIR, open-source models). 2) Containerized deployments for portability. 3) Data export capabilities required in all vendor contracts. 4) Abstraction layers between application logic and AI services. |
| **Owner** | Technical Architect |

### R-009: Patient Data Privacy Concerns
| Attribute | Value |
|-----------|-------|
| **Category** | Regulatory / Reputational |
| **Likelihood** | 3 (Possible) |
| **Impact** | 4 (Major) |
| **Risk Score** | 12 -- MEDIUM |
| **Description** | Patients may have concerns about AI being used with their health data, especially for clinical applications. Negative publicity could damage patient trust and clinic reputation. |
| **Mitigation Strategy** | 1) Transparent patient communication about AI use. 2) Opt-in consent for non-essential AI features. 3) De-identification for analytics. 4) Clear privacy policies. 5) Patient advisory input. |
| **Owner** | MedTech Privacy Officer |

### R-010: AI Model Bias in Clinical Applications
| Attribute | Value |
|-----------|-------|
| **Category** | Ethical / Clinical |
| **Likelihood** | 2 (Unlikely for Phase 1-2) |
| **Impact** | 5 (Critical) |
| **Risk Score** | 10 -- MEDIUM |
| **Description** | AI models trained on biased data could produce inequitable outcomes for patient subpopulations, particularly in clinical decision support or risk stratification. |
| **Mitigation Strategy** | 1) Bias testing for all clinical AI models. 2) Diverse training data requirements. 3) Human oversight on all clinical AI outputs. 4) Regular model auditing. 5) Defer clinical AI to later phases after data maturity. |
| **Owner** | ML Engineer + CMO |

### R-011: Multi-Site Rollout Complexity
| Attribute | Value |
|-----------|-------|
| **Category** | Operational |
| **Likelihood** | 3 (Possible) |
| **Impact** | 3 (Moderate) |
| **Risk Score** | 9 -- MEDIUM |
| **Description** | Each clinic may have different workflows, staff capabilities, patient populations, and local requirements that complicate standardized rollout. |
| **Mitigation Strategy** | 1) Pilot at one clinic first. 2) Document clinic-specific variations during discovery. 3) Configurable solution design. 4) Per-clinic rollout plans with local champions. |
| **Owner** | Implementation Lead |

### R-012: Third-Party/Vendor Dependencies
| Attribute | Value |
|-----------|-------|
| **Category** | Technical / Operational |
| **Likelihood** | 3 (Possible) |
| **Impact** | 3 (Moderate) |
| **Risk Score** | 9 -- MEDIUM |
| **Description** | Dependence on EHR vendor cooperation, payer API availability, and cloud service reliability introduces external dependencies beyond project control. |
| **Mitigation Strategy** | 1) Identify critical vendor dependencies early. 2) Engage vendors during discovery. 3) Build fallback approaches. 4) SLA requirements in vendor contracts. |
| **Owner** | Technical Architect |

### R-013: Cybersecurity Threats During Transformation
| Attribute | Value |
|-----------|-------|
| **Category** | Security |
| **Likelihood** | 3 (Possible) |
| **Impact** | 4 (Major) |
| **Risk Score** | 12 -- MEDIUM |
| **Description** | New systems, integrations, and cloud services expand the attack surface during implementation. Healthcare is a top target for ransomware and data breaches. |
| **Mitigation Strategy** | 1) Security assessment during discovery. 2) Penetration testing before go-live. 3) Zero-trust architecture. 4) Security monitoring for new systems. 5) Incident response plan review. |
| **Owner** | MedTech Security Officer + Technical Architect |

### R-014: Loss of Key Stakeholders
| Attribute | Value |
|-----------|-------|
| **Category** | Organizational |
| **Likelihood** | 2 (Unlikely) |
| **Impact** | 4 (Major) |
| **Risk Score** | 8 -- MEDIUM |
| **Description** | Departure of key stakeholders (CTO, CEO, physician champions) could derail the initiative or shift priorities. |
| **Mitigation Strategy** | 1) Broad stakeholder engagement (not single-threaded). 2) Documented strategy and rationale. 3) Governance structure that survives personnel changes. 4) Multiple executive sponsors. |
| **Owner** | Engagement Lead |

---

## Low Risks

### R-015: Technology Obsolescence
| Attribute | Value |
|-----------|-------|
| **Category** | Technical |
| **Likelihood** | 2 (Unlikely) |
| **Impact** | 2 (Minor) |
| **Risk Score** | 4 -- LOW |
| **Description** | AI/ML technology evolves rapidly; solutions implemented today may be superseded. |
| **Mitigation Strategy** | Modular architecture; abstraction layers; regular technology reviews. |

### R-016: Project Fatigue
| Attribute | Value |
|-----------|-------|
| **Category** | Organizational |
| **Likelihood** | 2 (Unlikely in Phase 1) |
| **Impact** | 3 (Moderate) |
| **Risk Score** | 6 -- LOW |
| **Description** | Multi-year transformation timeline could lead to stakeholder fatigue and reduced engagement. |
| **Mitigation Strategy** | Quick wins for early momentum; celebrate milestones; regular value reporting. |

### R-017: Competing Organizational Priorities
| Attribute | Value |
|-----------|-------|
| **Category** | Strategic |
| **Likelihood** | 3 (Possible) |
| **Impact** | 2 (Minor) |
| **Risk Score** | 6 -- LOW |
| **Description** | New business priorities (acquisitions, regulatory changes, market shifts) could divert attention and resources. |
| **Mitigation Strategy** | Executive steering committee; alignment with business strategy; flexible roadmap. |

---

## Risk Review Cadence

| Activity | Frequency | Responsible |
|----------|-----------|-------------|
| Risk register review and update | Weekly during active phases | Engagement Lead |
| Risk status report to steering committee | Monthly | Engagement Lead |
| Comprehensive risk reassessment | Per phase transition | Engagement Lead + CTO |
| HIPAA-specific risk review | Quarterly | Privacy Officer + Engagement Lead |

---

## Change Log

| Date | Version | Change | Author |
|------|---------|--------|--------|
| [Date] | 0.1 | Initial preliminary risk register | [Your Name] |
